Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 374

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Severe chronic neutropenia: Treatment and follow‐up of patients in the Severe Chronic Neutropenia International Registry

Open access
Dale, David C., Cottle, Tammy E., Fier, Carol J., Bolyard, Audrey Anna, Bonilla, Mary Ann, Boxer, Laurence A., Cham, Bonnie, Freedman, Melvin H., Kannourakis, George, Kinsey, Sally E., Davis, Robert, Scarlata, Debra, Schwinzer, Beate, Zeidler, Cornelia, Welte, Karl·2003·American Journal of Hematology

Abstract

Severe chronic neutropenia (SCN) is defined as an absolute neutrophil (ANC) of less than 0.5 × 10 9/L, lasting for months or years. Congenital, cyclic, and idiopathic neutropenia are principal categories of SCN. Since 1994, the Severe Chronic Neutropenia International Registry (SCNIR) has collected data to monitor the clinical course, treatments, and disease outcomes for SCN patients. This report summarizes data for 853 patients, almost all treated with daily or alternate‐day recombinant human granulocyte colony‐stimulating factor (G‐CSF or Filgrastim). G‐CSF treatment increased the ANC overall from 0.34 × 10 9/L ± 0.018 pre‐treatment to 3.70 × 10 9/L ± 0.18 during the first year of treatment. For most patients, the responses were durable with patients remaining on the same dose of G‐CSF for many years. Long‐term hematological observations showed stable mean leukocyte and neutrophil counts and gradually increasing hemoglobin levels. Thrombocytopenia developed in 4% of patients. As of January 1, 2000, myelodysplasia (MDS) or acute myelogenous leukemia (AML) has occurred in 35 of 387 patients with congenital neutropenia with a cumulative risk of 13% after 8 years of G‐CSF treatment. This event occurred without a predictable relationship to the duration or dose of G‐CSF treatment. No patients with cyclic or idiopathic neutropenia developed MDS or AML. Other important adverse events included hepatomegaly, osteoporosis, vasculitis, glomerulonephritis, and deaths in 4 of 14 cases requiring splenectomy. Growth and development and the outcome of pregnancy appeared to be unaffected by G‐CSF treatment. These data indicate that congenital, cyclic, and idiopathic neutropenia can be effectively treated with long‐term G‐CSF. The risk of leukemia, osteoporosis, other potentially adverse events, and pregnancy outcome need to be further evaluated with continuing long‐term observations. Am. J. Hematol. 72:82–93, 2003. © 2003 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ajh.10255

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 374

Metadata

Authors
Dale, D. C., Cottle, T. E., Fier, C. J., Bolyard, A. A., Bonilla, M. A., Boxer, L. A., Cham, B., Freedman, M. H., Kannourakis, G., Kinsey, S. E., Davis, R., Scarlata, D., Schwinzer, B., Zeidler, C., & Welte, K.
Venue
American Journal of Hematology
Publisher
Wiley
Published
2003-01-28
Volume
72
Issue
2
Pages
82-93
ISSN
  • 0361-8609 (ISSN-L)
  • 1096-8652
OpenAlex
W2048360052
Cited by
374
References
24
FWCI
11.39
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Severe chronic neutropenia: Treatment and follow‐up of patients in the Severe Chronic Neutropenia International Registry. https://app.cochat.ai/papers/10.1002/ajh.10255
The paper
Dale, D. C., Cottle, T. E., Fier, C. J., Bolyard, A. A., Bonilla, M. A., Boxer, L. A., Cham, B., Freedman, M. H., Kannourakis, G., Kinsey, S. E., Davis, R., Scarlata, D., Schwinzer, B., Zeidler, C., & Welte, K. (2003). Severe chronic neutropenia: Treatment and follow‐up of patients in the Severe Chronic Neutropenia International Registry. American Journal of Hematology. https://doi.org/10.1002/ajh.10255

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.